| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9975353 | The Journal of Heart and Lung Transplantation | 2005 | 7 Pages |
Abstract
An earlier impression that RATG is superior to OKT3 induction therapy has borne true in terms of overall survival and incidence of BOS, acute rejection and infection rates. Lung transplantation, using RATG induction therapy, remains an important modality for end-stage pulmonary disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Susan D. MD, PhD, Philippe MD, Robert C. MD, Ramona MD, Ann MD, Noreen MD, James MD, Bruce A. MD, Richard I. MD,